Talecris Biotherapeutics Holdings second-quarter 2010 net revenue increases 7.3% to $402.8 million
Talecris Biotherapeutics Holdings second-quarter 2010 net revenue increases 7.3% to $402.8 million
Talecris Biotherapeutics Holdings Corp. today announced its financial results for the three and six months ended June 30, 2010 and filed its 2010 Form 10-Q with the U.S. Securities and Exchange Commission.
Read more on News-Medical-Net